Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Is ‘Getting More Aggressive’ In Going After Drug Efficacy Claims Outside Label
Dec 06 2023
•
By
Brenda Sandburg
FDA is giving greater scrutiny to prescription drug promotions that overstate efficacy • Source: Shutterstock
More from Marketing & Advertising
More from Compliance